Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
Cannabis producer MediPharm Labs Corp. (TSX:LABS) (OTC:MEDIF) said Thursday it will launch MediPharm Labs-branded products covering both the medical and recreational markets in Canada.
MediPharm Labs CBD REGULAR FORMULA 25 is a 25-to-1, high-CBD, low THC oil with around 25mg/Ml of CBD to 1mg of THC.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
The product is crafted with full-spectrum cannabis concentrate produced at MediPharm's facility.
Other products from the new line are expected to hit the shelves in the upcoming weeks and months, the company said.
“We are thrilled to be launching MediPharm Labs’ first branded products, answering the call from consumers and retailers for more choice of high-quality, innovative cannabis products,” CEO Pat McCutcheon said in a statement.
“True to our pharma roots, based on a foundation of quality, our first branded product is a high-concentration CBD oil, created by our expert pharmaceutical team, specifically for medical and wellness purposes."
Want Private Access to Benzinga Analyst?
Check out the latest strategies our team of experts are using every week so that you can always adapt to the market like the pros!—Get FULL Access to This Week's Webinar Here.
The maker of pharmaceutical quality cannabis oil and concentrates operates a Good Manufacturing Practices-certified facility with ISO standard-build clean rooms, which the company said enables it to produce premium products that meet consumer demand.
McCutcheon touted MediPharm's focus on "purity, potency and price" as reasons for the lab's CBD being Canada’s preferred choice.
MediPharm said it plans to reach around 1.1 million Canadian medical marijuana consumers, distributing the new products via a variety of channels.
MediPharm shares were trading 3.42% higher at $1.64 at the time of publication Thursday.
Photo courtesy of MediPharm.
Related Links:
MediPharm Labs Partners With Shoppers Drug Mart
Cronos Group Reportedly Under SEC Investigation, Targeted In Shareholder Class Action Lawsuit
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.